Dynaglipt L Tablet 10's
₹67.5*
MRP ₹75
10% off
₹64*
MRP ₹75
15% CB
₹11 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
Dynaglipt L Tablet is used to treat type 2 diabetes in adults along with diet and lifestyle changes. It is used alone or in combination with other drugs to lower blood sugar levels. People with type 2 diabetes either do not produce enough insulin, or the insulin produced cannot perform its function in the body (insulin resistance). Middle-aged or older individuals are most likely to suffer from type 2 diabetes, also known as adult-onset diabetes.
Dynaglipt L Tablet contains Linagliptin, which belongs to the class of dipeptidyl peptidase-4 (DPP-4) inhibitors. It works by blocking the action of DPP-4, an enzyme that destroys the hormone Incretin. The enzyme 'Incretins' helps produce more insulin only when required and reduces the liver's blood sugar level when not needed.
The most common side effects of Dynaglipt L Tablet are hypoglycaemia (low blood glucose levels), upper respiratory tract infection, nasopharyngitis (infection of nose and throat with common cold), and headache. Most of these side effects may not require medical attention and resolve gradually overtime. However, if the side effects persist or worsen, consult the doctor.
Do not take Dynaglipt L Tablet if you are allergic to any of its components. If you stop taking Dynaglipt L Tablet abruptly, it may increase your sugar levels, which could further increase the risk of eyesight loss (retinopathy), kidney (nephropathy) and nerve damage (neuropathy). Dynaglipt L Tablet should not be taken if you have severe kidney or liver disease. Please inform your doctor if you have any heart disease or if you are pregnant, planning to get pregnant or breastfeeding.
Dynaglipt L Tablet is primarily used to treat Type 2 diabetes mellitus. It contains Linagliptin, which belongs to the class of dipeptidyl peptidase-4 (DPP-4) inhibitors used Dynaglipt L Tablet is prescribed for type 2 diabetes when diet and exercise alone cannot control blood sugar levels. It works by blocking the action of DPP-4 (an enzyme that destroys the hormone ‘Incretin’). The enzyme ‘Incretins’ helps produce more insulin only when required and reduces the liver's blood sugar level when not needed. Dynaglipt L Tablet should not be used in patients with type 1 diabetes and for the treatment of diabetic ketoacidosis. Thus, Dynaglipt L Tablet plays a vital role in controlling blood sugar levels and prevents serious complications of diabetes like eyesight loss (retinopathy), kidney (nephropathy), nerve damage (neuropathy), diabetic foot ulcer and delayed wound healing.
Dynaglipt L Tablet should not be taken if you are allergic to Dynaglipt L Tablet or any of its ingredients. Please inform your doctor if you are pregnant or breastfeeding before starting Dynaglipt L Tablet . Prolonged intake of Dynaglipt L Tablet may cause acute pancreatitis (swollen pancreas) and critical kidney problems. Increased risk of hypoglycaemia (low blood sugar level) can occur when Dynaglipt L Tablet is added to other anti-diabetic agents or insulin therapy. In this case, your doctor may adjust the dose of Dynaglipt L Tablet . Severe allergic reactions might occur in some patients taking Dynaglipt L Tablet , like anaphylaxis, angioedema (swelling under the skin), and exfoliative skin conditions, including Stevens-Johnson syndrome. Safety and efficacy of Dynaglipt L Tablet in children under 18 years have not been established, so it should not be given to them. Patients taking digoxin (a heart medicine) with Dynaglipt L Tablet should be closely monitored as severe drug interaction has been observed. Dynaglipt L Tablet should not be used in patients with type 1 diabetes and for the treatment of diabetic ketoacidosis.
Drug-Drug Interactions: Dynaglipt L Tablet interacts with heart condition drugs (digoxin), diuretic (furosemide), steroids (budesonide), antibiotic (rifampin), anti-epileptic drugs (phenytoin, topiramate, lamotrigine), heart-related chest medicine (ranolazine), Beta-blocker medications ( metoprolol, propranolol, glaucoma eye drops such as timolol) insulin, and other antidiabetic medicines.
Drug-Food Interactions: Intake of excessive alcoholic beverages may increase the chance of a life-threatening condition known as Lactic Acidosis. So, avoid intake of alcoholic beverages with Dynaglipt L Tablet . Also, inform your doctor if you are taking St. John's wort (a natural remedy for depression).
Drug-Disease Interactions: Dynaglipt L Tablet may interact if taken in heart problems, high triglycerides (a type of fat in the blood), pancreatitis, gallstones, alcoholism, and kidney problem.
Diabetes (Type 2): It is a condition where the body cannot make sufficient insulin, or the insulin that it makes doesn't work properly or is utilized by our body. This can cause high blood sugar levels (hyperglycemia). Type 2 diabetes symptoms include increased thirst, frequent urination at night, slow wound healing, increased hunger, fatigue, and blurred vision. There may be weight gain in some cases, while in rare cases, weight loss may be observed. The complications of type 2 diabetes also include neuropathy (nerve problems), nephropathy (kidney problems), retinopathy (damaged retina of eyes or blindness), loss of limbs, sexual dysfunction, and an increase in the chance of heart attack or stroke.
Alcohol
Unsafe
Alcohol should not be consumed along with Dynaglipt L Tablet as it is known to interact and lead to unpleasant side effects.
Pregnancy
Caution
Dynaglipt L Tablet is a category B pregnancy medication. So, its safety in pregnant women is not established. So, it should be taken only if prescribed by a doctor.
Breast Feeding
Caution
It is not known whether Dynaglipt L Tablet passes through the breast milk or not. So, it should be taken only if prescribed by a doctor.
Driving
Caution
Dynaglipt L Tablet has no influence on the ability to drive and use machines. However, dizziness and drowsiness have been reported, which may affect your ability to drive or use machines.
Liver
Caution
If u have or had a history or evidence of any liver-related diseases, please consult the doctor before taking medicine.
Kidney
Caution
If u have or had a history or evidence of any kidney-related diseases, please consult the doctor before taking medicine.
Children
Unsafe
Dynaglipt L Tablet is not recommended for children below the age of 18 years.
Country of origin
Manufacturer/Marketer address
We provide you with authentic, trustworthy and relevant information
Customers Also Bought
Product Substitutes